Biosensors Market Dominated by Electrochemical Sensors with 72% Revenue Share, as Global Biosensors Market Size is set to Surpass USD 42B by 2030, Says Mordor Intelligence

Key Market Insights  Key Market Insights   Rise in  Point-of-Care  and Home-Based Testing   The growing need for accessible, real-time diagnostics has accelerated the deployment of biosensors in portable and home-based testing devices. Patients and clinicians are increasingly relying on point-of-care systems that deliver accurate results within minutes, particularly for chronic conditions like diabetes and cardiovascular diseases. This shift is reshaping diagnostic delivery models and...

HYDERABAD, India, 18/11/2025 (informazione.news - comunicati stampa - salute e benessere)

Key Market Insights 

Rise in Point-of-Care and Home-Based Testing 
The growing need for accessible, real-time diagnostics has accelerated the deployment of biosensors in portable and home-based testing devices. Patients and clinicians are increasingly relying on point-of-care systems that deliver accurate results within minutes, particularly for chronic conditions like diabetes and cardiovascular diseases. This shift is reshaping diagnostic delivery models and boosting adoption among both healthcare providers and consumers. 

Growing Adoption Across Non-Medical Applications 
Beyond healthcare, biosensors are finding increasing use in food safety, environmental analysis, and bioprocess monitoring. Industries are adopting biosensor-based systems for detecting contaminants, monitoring pollutants, and ensuring regulatory compliance. This cross-sector expansion broadens the commercial potential of the biosensors market, diversifying revenue streams for manufacturers and technology developers. 

Regional Market Outlook 

North America continues to dominate the global biosensors market, driven by a mature healthcare ecosystem, high R&D investment, and strong demand for advanced diagnostic technologies. The United States leads the region with widespread integration of biosensors in medical devices and digital health systems. 

Asia-Pacific is projected to exhibit the fastest growth through 2030, supported by expanding healthcare infrastructure, increasing prevalence of chronic diseases, and a growing base of tech-driven medical device startups. Government initiatives promoting healthcare innovation in China, Japan, and India are further catalyzing regional adoption. 

Market Segment Breakdown 

By Product Type

By Technology 

By Application 

By End User 

By Geography 

For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report: 
https://www.mordorintelligence.com/industry-reports/biosensors-market?utm_source=prnewswire 

Strategic Competitive Environment 

The biosensors market is moderately fragmented, with global players investing in advanced sensing technologies, miniaturization, and wireless data integration. Partnerships between biosensor manufacturers, diagnostics companies, and tech innovators are driving new product launches and expanding application diversity. Strategic collaborations and acquisitions remain key approaches to enhance market share and access emerging healthcare segments. 

Key Companies Include: 

Check out related reports published by Mordor Intelligence:

Coronary Stent Market: The coronary stents market is segmented by product type (drug eluting stent, bare metal coronary stent), biomaterial (metallic, polymeric), mode of delivery (balloon-expandable stent and self-expanding stent), end user (hospitals, ambulatory surgical centers), and geography (North America, Europe, Asia-Pacific, and More). 

Therapeutic Drug Monitoring Market: The therapeutic drug monitoring market is segmented by technology (immunoassays, proteomic), drug class (antiarrhythmic drugs, immunosuppressants), end-user (hospital laboratories, independent / reference laboratories), and geography. 

Thermo Fisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation ( Beckman Coulter, Inc.) and Siemens Healthcare GmbH are the major companies operating in this market. 

Read more about companies active in Therapeutic Drug Monitoring: https://www.mordorintelligence.com/industry-reports/therapeutic-drug-monitoring-market/companies?utm_source=prnewswire 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries, please contact: 
media@mordorintelligence.com

https://www.mordorintelligence.com/contact-us 

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/biosensors-market-dominated-by-electrochemical-sensors-with-72-revenue-share-as-global-biosensors-market-size-is-set-to-surpass-usd-42b-by-2030-says-mordor-intelligence-302618375.html